Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-30T15:40:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice about replacing the term “Artificial Intelligence” with “Super Intelligence” during a terminology transition appears above the study record.
    Difference
    0.8%
    Check dated 2026-10-23T17:36:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-16T20:51:10.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-09T20:54:49.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-18T18:35:43.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new entry for Revision: v3.6.6 was added to the Study Record History, replacing Revision: v3.6.5. This indicates a site release update applied to the ClinicalTrials.gov records.
    Difference
    0.1%
    Check dated 2026-08-28T17:34:17.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.